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INTRODUCTION 
Polyfibromatosis syndrome is a rare disease with unknown
etiology, and is characterized by cutaneous keloid formation,
fibromatoses of diverse sites including palmar, plantar, penile,
and knuckle areas, and erosive changes of the hand and foot
joints (1, 2). In 1945, Tourain et al. (3) first described hered-
itary polyfibromatosis as a rare syndrome that mainly pre-
sented with various connective tissue changes. Pierard et al.
(1) identified osteolysis of joints in a patient with phenytoin-
related polyfibromatosis. Histopathological findings of ero-
sive arthropathy were first reported in a patient with an aggres-
sive form of polyfibromatosis syndrome (4). A follow-up pre-
sentation in the same patient was described after 10 yr with-
out any suggestions of effective treatments or definite etiol-
ogy (5). The precise pathogenesis and clinical or radiograph-
ic characteristics of this disease entity remain unclear, although
some investigators have attempted to identify the pathogen-
esis in respect to genetic backgrounds or mechanical prop-
erties (6, 7). 
Clinical and radiological characteristics for erosive arthro-
pathy in polyfibromatosis have rarely been described, altho-
ugh comments about the presence of arthropathy in some
cases have been presented in the literature (1, 4, 5, 8). Here,
we described the radiological and clinical features for erosive
arthropathy in our case and reviewed erosive arthropathy for
cases with polyfibromatosis syndrome in previous reports.
CASE REPORT
A 44-yr-old male visited our rheumatology clinic because
of painless progressive deformities of his hands and feet, in
addition to multiple dysmorphic skin lesions with keloid
formation on the whole body, especially the chest wall and
extremities. Over the next eight years, painless deformities
in his hands and feet gradually progressed, leading to the
severe palmar and plantar contractures that were seen at his
first visit to our clinic. He denied any signs of either articu-
lar or periarticular inflammation, such as heat, swelling, or
tenderness, during the course of this condition. His family
history and drug history were unremarkable. 
Keloid formations were visible on his left shoulder, ante-
rior chest wall, both arms, and right leg due to previous in-
juries including BCG vaccination, thoracostomy site, and
blunt traumas. There were ulcerated keloid skin lesions on
both of his feet, to which he denied any antecedent trauma.
His hands and feet revealed severe flexion deformities with-
out signs of active inflammation in any of his joints. Nod-
ules in his palm and sole also were also identified.
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Erosive Arthropathy with Osteolysis As a Typical Feature in 
Polyfibromatosis Syndrome: A Case Report and a Review of the 
Literature
Polyfibromatosis syndrome is a rare disease entity that is characterized by various
clinical features such as palmar, plantar, and penile fibromatoses, keloid formations
of the skin, and erosive arthropathy. Its precise pathophysiology or etiology remains
unclear. In addition to distinctive diverse skin manifestations, patients with polyfi-
bromatosis have been previously reported to show erosive arthropathy with signifi-
cant limitation of movement at affected joints. However, the presence of erosive
polyarthropathy in polyfibromatosis has not emphasized in previous cases. Here,
we report a case of polyfibromatosis syndrome combined with painless massive
structural destruction of hand and foot joints, and review the characteristics of ero-
sive arthropathy in previous cases.
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The complete blood count, liver and renal function tests,
muscle enzymes, and urinalysis of the patient were normal.
Antinuclear antibody, antineutrophilic cytoplasmic antibody,
and rheumatoid factor tests were negative, and acute phase
reactants such as erythrocyte sediment rate (ESR) and c-reac-
tive protein (CRP) were also within normal range. Pulmonary
function tests and nailfold capillary microscopy did not show
abnormal findings. Plain radiography of both hands revealed
multiple erosive lesions with sclerotic margins or a punch-out
appearance in his metacarpophalangeal (MCP) and proximal
interphalangeal (PIP) joints and resorptive changes (acrolysis)
in distal phalanges (Fig. 1A). A coronal T1-weighed mag-
netic resonance image (MRI) demonstrated erosive changes
at the MCP and PIP joints of the right hand after radio-con-
trast administration (Fig. 1B). Biopsies of the cutaneous lesions
on the trunk showed dermal fibrous proliferation consistent
with keloid formations (Fig. 2).
We diagnosed the patient with polyfibromatosis syndrome
due to evidence of visible typical skin lesions with compati-
ble pathologic findings on multiple sites and articular or
periarticular manifestations such as joint deformities accom-
panied with skin contractures and nodular formations. Even
though we have tried various treatments over the past years,
including D-penicillamine, intralesional and medium-dose
oral steroids, colchicine, and intravenous cyclophosphamide,
none of these have been effective on either his cutaneous or
articular manifestations. 
DISCUSSION 
Polyfibromatosis syndrome is known for complex fibros-
ing conditions including knuckle pads, palpable fibrotic nod-
ules of penile area (Peyronie’s disease), plantar fibromatosis
(Ledderhose’s disease), plamar fibromatoses (Dupuytren’s con-
tractures), and keloid formations (3). The pathogenesis of
polyfibromatois syndrome itself has not yet been determined,
although research on the pathophysiology of some compo-
nents in polyfibromatosis syndrome such as Dupuytren’s con-
tractures and Peyronie’s disease are relatively well-described
(9, 10). 
Here, we focused on the massive erosive arthropathy in
polyfibromatosis syndrome (Table 1). Polyfibromatosis syn-
drome accompanied with erosive polyarthropathy is a rare
dermatoarthropathy (1, 4, 5, 8) after the first historical des-
cription for polyfibromatosis syndrome by Tourain et al. (3)
in 1945. It seems that the presence of arthropathy in a patient
Fig. 1. (A) Hand radiography showing multiple erosions with sclerotic margin at the PIP and MCP joints with flexion deformities of the hand
due to Dupuytren’s contractures. Resorptive changes (acrolysis) at distal phalanges of both hands were also noted. (B) Coronal T1-weighted
spin-echo image (TR/TE 600/29) of the right hand showed multiple bony erosions at the MCP and PIP joints and fatty replacement in soft
tissue. 
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Fig. 2. The biopsy demonstrated fibrous changes composed of
interlacing bundles of collagens and fibroblasts in deep dermis
and subcutaneous tissue (H&E stain ×40). 328 S.-K. Kim, H.J. Kim, Y.H. Lee, et al.
with phenytoin-related polyfibromatosis was first described
by Pierard et al. (1) in 1979, although Black et al. (4) used
the term ‘erosive arthropathy’ in their description. Pierard
et al. first described a 20-yr-old Caucasian male with polyfi-
bromatosis and erosive arthropathy associated with pheny-
toin-dependent fibrosis, who presented with diverse skeletal
abnormalities including camptodactyly, facial bone hypopla-
sia, scoliosis, and osteolytic changes of the wrists, hands, and
feet joints (1). Then, histopathologic findings on bone biop-
sy from a finger with erosive arthropathy in a 48-yr-old West-
ern Indian man with aggressive polyfibromatosis was des-
cribed by Black et al. (4). The biopsy results showed an in-
creased number of osteoclasts associated with erosion of tra-
becular bone. Recently, a novel case of polyfibromatosis syn-
drome combined with interstitial granulomatous dermatitis
and arthritis was also reported in the literature (8). Radiolog-
ic findings in a new form of an Australian case were also simi-
lar with the previous cases of polyfibromatosis syndrome.
This case included the first description of radiographic fea-
tures in erosive arthropathy of polyfibromatosis syndrome
by advanced radiologic imaging modalities such as MRI. 
The pathogenesis underlying the combined articular and
cutaneous manifestations seen in aggressive polyfibromatosis
syndrome is unknown. There may be common triggering fac-
tors causing not only an abnormal balance between the pro-
liferation and apoptosis of dermal fibroblasts leading to super-
ficial fibromatosis and keloid formation (11, 12), but also
that of synovial fibroblasts stimulating the differentiation
and activation of osteoclasts that lead to joint erosion (13). 
Possible differential diagnosis for punch-out bony erosion
and osteolysis in the radiographic findings of this patient
without any symptomatic signs or symptom of joint inflam-
mation may include Gorhan-stout syndrome, chronic gout
arthritis, nodulosis, arthropathy, osteolysis (NAO) syndrome,
or neuropathic arthropathy. Gorham-stout syndrome is a rare
disorder that is characterized by massive bone matrix loss with
swelling or pain in an affected joint, and is mainly involved
in a single joint (14). The distribution of involved joints and
MRI findings with enhancement of synovia, marrow, and soft
tissue after contrast administration in Gorhan-stout syndrome
differed from those in polyfibromatosis syndrome without
enhanced lesions. In addition, we could exclude chronic gouty
arthritis in diagnosis with respect to the normal range of se-
rum uric acid and absence of typical clinical manifestations
of gout. NAO syndrome has an unknown origin that main-
ly presents with nodulosis and arthropathy with deformed
joints (15). This syndrome could be differentiated from our
case because it was an autosomal recessive trait, showed early
onset of disease, and was responsive to medication. Consid-
ering the prevalent sites of involved joints or the presence of
underlying diseases such as syphilis, syringomyelia, or dia-
betes, neuropathic arthropathy could be excluded. 
With respect to the treatment of polyfibromatosis syn-
drome, although various treatments were tried, including
steroids, potassium para-aminobenzoic acid, D-penicillamine,
methotrexate, minoxidil, and isotretinoin, none of these ther-
apies showed efficacy during a follow-up period of up to 10
yr (4, 5). Our case was also treated with D-penicillamine,
intralesional and medium-dose oral steroids, colchicine, and
intravenous cyclophosphamide, but these trials resulted in
no response. 
We proposed a possible association between polyfibromato-
sis syndrome and erosive arthropathy from the results of our
literature review. Our case offers information on another dis-
order in which rheumatological and dermatological mani-
festations occurred together. Thus, physicians should be aware
of the considerable overlap between the two specialties and
increase collaborations to elucidate an etiologic link and,
hopefully, an effective treatment. 
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